Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study

Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study

Background Angiotensin-converting enzyme 2 facilitates the entry of severe acute respiratory syndrome coronavirus 2 into the human body. We investigated the association of renin-angiotensin-aldosterone system (RAAS) inhibitor use with severe coronavirus disease 2019 (COVID-19) outcomes in hypertensi...

Full description

Bibliographic Details
Main Authors: Jae Hyun Bae, Sun Kyu Choi, Nam Hoon Kim, Juneyoung Lee, Sin Gon Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2021-05-01
Series:Diabetes & Metabolism Journal
Subjects:
angiotensin-converting enzyme inhibitors
angiotensin receptor antagonists
covid-19
hypertension
renin-angiotensin system
respiration, artificial
Online Access:http://e-dmj.org/upload/pdf/dmj-2020-0279.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-2020-0279.pdf

Similar Items